RARE ULTRAGENYX PHARMACEUTICAL INC Investments/Divestments 8-K Filing 2024 - Public Offering Ultragenyx Pharmaceutical Inc. entered into an underwriting agreement for a public offering of shares and pre-funded warrants, expected to close on June 17, 2024, with net proceeds of approximately $330.7 million.Get access to all SEC 8-K filings of the ULTRAGENYX PHARMACEUTICAL INC